Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-14-019515
Filing Date
2014-11-04
Accepted
2014-11-04 17:20:48
Documents
11
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q ipxl20140930_10q.htm 10-Q 1825748
2 EXHIBIT 31.1 ex31-1.htm EX-31 18110
3 EXHIBIT 31.2 ex31-2.htm EX-31 18625
4 EXHIBIT 32.1 ex32-1.htm EX-32 7400
5 EXHIBIT 32.2 ex32-2.htm EX-32 7543
  Complete submission text file 0001437749-14-019515.txt   11447718

Data Files

Seq Description Document Type Size
6 EXHIBIT 101.INS ipxl-20140930.xml EX-101.INS 2040926
7 EXHIBIT 101.SCH ipxl-20140930.xsd EX-101.SCH 81682
8 EXHIBIT 101.CAL ipxl-20140930_cal.xml EX-101.CAL 47270
9 EXHIBIT 101.DEF ipxl-20140930_def.xml EX-101.DEF 324574
10 EXHIBIT 101.LAB ipxl-20140930_lab.xml EX-101.LAB 451090
11 EXHIBIT 101.PRE ipxl-20140930_pre.xml EX-101.PRE 325414
Mailing Address 30831 HUNTWOOD AVENUE HAYWARD CA 94544
Business Address 30831 HUNTWOOD AVENUE HAYWARD CA 94544 510-240-6000
IMPAX LABORATORIES INC (Filer) CIK: 0001003642 (see all company filings)

EIN.: 650403311 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34263 | Film No.: 141194204
SIC: 2834 Pharmaceutical Preparations